INTRACEREBRAL HAEMORRHAGE:

Similar documents
Starting or Resuming Anticoagulation or Antiplatelet Therapy after ICH: A Neurology Perspective

Restart or stop antithrombotics after intracerebral haemorrhage (ICH)?

A common clinical dilemma. Ischaemic stroke or TIA with atrial fibrillation MRI scan with blood-sensitive imaging shows cerebral microbleeds

Classification of Intracerebral Haemorrhages

Intracranial spontaneous hemorrhage mechanisms, imaging and management

Hypertensive Haemorrhagic Stroke. Dr Philip Lam Thuon Mine

New Frontiers in Intracerebral Hemorrhage

Patients presenting with acute stroke while on DOACs

M. Edip Gurol, MD, MSc Stroke Service/Neurology, Massachusetts General Hospital, Harvard Medical School

Giuseppe Micieli Dipartimento di Neurologia d Urgenza IRCCS Fondazione Istituto Neurologico Nazionale C Mondino, Pavia

Modern Management of ICH

NEURORADIOLOGY Part I

Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage

Stroke & the Emergency Department. Dr. Barry Moynihan, March 2 nd, 2012

UPSTATE Comprehensive Stroke Center. Neurosurgical Interventions Satish Krishnamurthy MD, MCh

doi: /brain/awq246 Brain 2010: 133; What are the causes of pre-existing dementia in patients with intracerebral haemorrhages?

Acute Stroke Management Conference 2019: Stroke Clinical Vignettes

Direct oral anticoagulants for Embolic Strokes of Undetermined Source? George Ntaios University of Thessaly, Larissa/Greece

Angel J. Lacerda MD PhD, Daisy Abreu MD, Julio A. Díaz MD, Sandro Perez MD, Julio C Martin MD, Daiyan Martin MD.

Controversies in Hemorrhagic Stroke Management. Sarah L. Livesay, DNP, RN, ACNP-BC, ACNS-BC Associate Professor Rush University

The Epidemiology of Stroke and Vascular Risk Factors in Cognitive Aging

Significant cognitive improvement with cholinesterase inhibition in AD with cerebral amyloid angiopathy

In patients with spontaneous intracerebral hemorrhage

Antithrombotic therapy in patients with transient ischemic attack / stroke (acute phase <48h)

Acute stroke imaging

Cerebral small vessel disease

Diagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes

Recombinant Factor VIIa for Intracerebral Hemorrhage

Lothian Audit of the Treatment of Cerebral Haemorrhage (LATCH)

A report of nontraumatic cortical subarachnoid hemorrhage and subsequent management

Neuroanatomy of a Stroke. Joni Clark, MD Professor of Neurology Barrow Neurologic Institute

Sporadic cerebral amyloid angiopathy revisited: recent insights into pathophysiology and clinical spectrum

Luisa Vinciguerra. Ictus recidivanti

Overview of Stroke: Etiologies, Demographics, Syndromes, and Outcomes. Alex Abou-Chebl, MD, FSVIN Medical Director, Stroke Baptist Health Louisville

Cerebral microbleeds (CMBs) are detected on T2*-

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

When Not To Give TPA Steve Phillips Division of Neurology

Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage

Updates from 2017 International Stroke Conferences


UPDATE ON STROKE IN OLDER PEOPLE: CLINICAL CASES IN EVERYDAY PRACTICE

Anticoagulants and Head Injuries. Asaad Shujaa,MD,FRCPC,FAAEM Assistant Professor,weill Corneal Medicne Senior Consultant,HMC Qatar

Patent Foramen Ovale and Cryptogenic Stroke: Do We Finally Have Closure? Christopher Streib, MD, MS

Case Report Isolated Central Sulcus Hemorrhage: A Rare Presentation Most Frequently Associated with Cerebral Amyloid Angiopathy

ACUTE ISCHEMIC STROKE. Current Treatment Approaches for Acute Ischemic Stroke

Amyloid and the Vessels. David Weisman, M.D.

[(PHY-3a) Initials of MD reviewing films] [(PHY-3b) Initials of 2 nd opinion MD]

Investigators meeting. Thursday 7 June 2012

MBs present as homogeneous round lesions with signalintensity

Stroke - Intracranial hemorrhage. Dr. Amitesh Aggarwal Associate Professor Department of Medicine

ENCHANTED Era: Is it time to rethink treatment of acute ischemic stroke? Kristin J. Scherber, PharmD, BCPS Emergency Medicine Clinical Pharmacist

Role of recombinant tissue plasminogen activator in the updated stroke approach

Antithrombotics in Stroke management

Cerebrovascular diseases-2

Intracerebral Hemorrhage

TIA: Updates and Management 2008

The HEMORR 2 HAGES, ATRIA and the HAS-BLED bleeding risk prediction scores in anticoagulated atrial fibrillation patients : The AMADEUS study

10 May Disclosure. + Outline. Case-based approach to nontraumatic intracranial hemorrhage. Kathleen R. Fink, MD University of Washington

MODULE 1: Stroke Prevention in Atrial Fibrillation Benjamin Bell, MD, FRCPC

True cryptogenic stroke

A Patient Unsuitable for VKA Treatment

An Introduction to Imaging the Brain. Dr Amy Davis

Acute and chronic treatments

Case 9511 Hypertensive microangiopathy

Thrombolytic therapy should be the first line treatment in acute ishchemic stroke. We are against it!!

The three main subtypes of stroke

Atrial Fibrillation. Alan Bell, MD, CCFP. Staff Physician, Humber River Regional Hospital. University of Toronto

Magnetic resonance imaging (MRI) has the potential to

Cerebrovascular Disease

Manuel Castella MD PhD Hospital Clínic, University of

Life after ARUBA: Management of Unruptured Brain Arteriovenous Malformations (AVMs)

Michael Horowitz, MD Pittsburgh, PA

Stroke and Headache Headache and Stroke

11/1/2018. Disclosure. Imaging in Acute Ischemic Stroke 2018 Neuro Symposium. Is NCCT good enough? Keystone Heart Consultant, Stock Options

Neurosurgical Management of Stroke

Stroke imaging. Why image stroke patients? Stroke. Treatment of infarct. Methods for infarct diagnosis. Treatment of infarct.

PRESERVE: How intensively should we treat blood pressure in established cerebral small vessel disease? Guide to assessing MRI scans

Original Research Article

TRAUMATIC CAROTID &VERTEBRAL ARTERY INJURIES

Definition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure

Management of Intracerebral Haemorrhage

CEREBRO VASCULAR ACCIDENTS

MRI Imaging of GP Medicare Eligible Conditions

Stroke/TIA. Tom Bedwell

Disclosures. An Update on TIA and Minor Stroke. The Agenda PROGNOSIS PATHOPHYSIOLOGY GUIDELINES AND PROVEN MANAGEMENT STRATEGIES AGGRESSIVE TREATMENT

Small vessel disease and post stroke cognitive impairment

Silent Cerebral Strokes: Clinical Outcomes and Management

TRANSIENT ISCHEMIC ATTACK (TIA)

. 8. Pharmacological treatment in acute stroke 8.3 Antiplatelet and anticoagulant treatment in stroke due to arterial dissection

C. Douglas Phillips, MD FACR Director of Head and Neck Imaging Weill Cornell Medical College NewYork-Presbyterian Hospital

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

NOACs Update PD Dr. Jan Steffel Leitender Arzt, Klinik für Kardiologie Co-Leiter Rhythmologie Universitätsspital Zürich

Outlook for intracerebral haemorrhage after a MISTIE spell

Secondary Preven-on of Thromboembolic Stroke: Clinical Data and Recommenda-ons from the ESC Atrial Fibrilla-on Guideline Update 2012

Indications of Anticoagulants; Which Agent to Use for Your Patient? Marc Carrier MD MSc FRCPC Thrombosis Program Ottawa Hospital Research Institute

Stroke Update. Lacunar 19% Thromboembolic 6% SAH 13% ICH 13% Unknown 32% Hemorrhagic 26% Ischemic 71% Other 3% Cardioembolic 14%

Thrombolysis-WAKE UP Intra-arterial interventions DEFUSE 3 Haemorrhagic Stroke - TICH 2 Secondary Prevention CROMIS 2 Secondary Prevention NAVIGATE

La gestione dell ictus ischemico o emorragico nel paziente sotto NAO

Venous thrombosis in unusual sites

Treatment of Acute Hemorrhagic Stroke 5th QSVS Neurovascular Conference Dar Dowlatshahi MD PhD FRCPC Sept 14, 2012

Transcription:

INTRACEREBRAL HAEMORRHAGE: WHAT IS THE CAUSE? Prof. Charlotte Cordonnier Head, Department of neurology & stroke centre Director, Lille haemorrhagic stroke research program Lille University Hospital France charlotte.cordonnier@univ-lille2.fr

DISCLOSURES Stocks None Drug trials (< 5 years) Lundbeck 2011 Dias-3 (investigator) Brainsgate 2012 Impact-24 (investigator) Sanofi-Aventis 2012 ASY (investigator) Pierre Fabre 2013 LIFE (investigator) Pfizer 2014 A9951024 (PI France) Astra-Zeneca 2015 Socrates (investigator) Board (<5 years) Bayer Daiichi Sankyo - Medtronic Speaker honoraria (<2 years) None Travels (<1 year) None No personal funding - Funding to Research account (Lille University Hospital) or ADRINORD March

~3.4 MILLION NEW ICRH WORLDWIDE IN 2013 Ischaemic stroke Haemorrhagic stroke Neuroepidemiology 2015;45:161-76

RISK OF ICH INCREASES WITH AGE Overall ICH incidence has been stable for the last 30 years Van Asch C. Lancet Neurol 2010 Incidence rate 6.2/100 000/year in females 9.1/100 000/year in males Mean age at onset 67y in 1985-1992 versus 75y in 2002-2008 Impact of primary prevention Béjot Y, et al. Brain 2013

PROFILES OF PATIENTS ARE CHANGING UNDERLYING VESSEL DISEASE ARE CHANGING 50% decrease in <60y 80% increase in 75 & increased antithrombotic use Some bleeding prone vasculopathies are more likely to bleed when antithrombotics are used, especially in lobar ICH Béjot Y, et al. Brain 2013

FORGET PRIMARY Trauma Spontaneous With malformation Without malformation Risk factors? Hypertension Hypocholesterolemia Alcohol Precipitating factors? Antiplatelets Warfarin

FORGET PRIMARY Al Shahi Salman R et al. BMJ 2009; 339:b2586

2 MOST FREQUENT CAUSES DEEP versus LOBAR «Deep perforating vasculopathy» Cerebral Amyloid Angiopathy Thal JNEN 2003 Courtesy De Reuck J 2015

DEEP PERFORATING VASCULOPATHY Frequent cause of ICH Search for markers of small-vessel disease Leukoaraiosis Lacunes Other organ damage such as retina, heart, kidney?

DEEP PERFORATING VASCULOPATHY Woman, 68 years old HTN for 20 years Treatment at home: ACE inhibitors, diuretics

DEEP PERFORATING VASCULOPATHY Woman, 60 years old HTN for 15 years, diabetes for 5 years Treatment at home: calcium blockers

MRI Day 3 T2* GRE FLAIR

DEEP PERFORATING VASCULOPATHY Frequent cause of ICH Search for markers of small-vessel disease Leukoaraiosis Lacunes Other organ damage such as retina, heart, kidney? SEE the disease

CEREBRAL AMYLOID ANGIOPATHY

Registre PITCH CAA & ICH CAA is a common cause of lobar ICH 30% of lobar ICH in the elderly? 562 ICH 196 lobar ICH (35%) median age 75 (IQR 62-79) 29 (15%) no CAA 120 (61%) poss CAA 47 (24%) prob CAA Hochart A. et al, in preparation

Diagnostic criteria: the Boston criteria How to diagnose CAA in patients with ICH?

Boston criteria

How to improve the Boston criteria? Superficial siderosis Linn J. Neurology 2010

How to improve the Boston criteria? Superficial siderosis Linn J. Neurology 2010

CAA : 2 FACES OF A DISEASE Occlusive expression of the disease White-matter lesions Small cortical infarcts Microinfarcts (autopsy or high field MRI) Progression of CAA. Courtesy Dr Attems Gurol E. Ann Neurol 2012

CAA : 2 FACES OF A DISEASE Occlusive expression of the disease White-matter lesions Transient hypersignal DWI of presumed ischaemic origin Microinfarcts (autopsy or high field MRI) Smith E. Lancet Neurology 2012

CAA : 2 FACES OF A DISEASE Occlusive expression of the disease White-matter lesions Hypersignal in Double Inversion Recovery sequences Yuichiro L. J Neuroimaging 2013

CAA : 2 FACES OF A DISEASE Occlusive expression of the disease White-matter lesions Transient hypersignal DWI of presumed ischaemic origin Microinfarcts (autopsy or high field MRI) Smith E. Lancet Neurology 2012 Cordonnier C. Brain 2010

FORGET PRIMARY Al Shahi Salman R et al. BMJ 2009; 339:b2586

Courtesy Al-Shahi Salman R CLUES TO THE CAUSE OF ICH ON CT? Aneurysm Coagulopathy Trauma Venous thrombosis Arteriovenous malformation

Early CTA: diagnostic yield 17% CTA/MR/DSA: 23% Van Asch CJJ. BMJ 2015

HOW TO INVESTIGATE ICH PATIENTS? No consensus CTA Cordonnier C. Stroke 2010 identifies around ¾ macrovascular causes of ICH widely available, feasible in patients with a poor clinical condition few complications BUT lower yield than expected MRI/MRA Van Asch CJJ. BMJ 2015 high accuracy for detection of macrovascular causes as a first diagnostic modality Josephson CB. Cochrane Database Syst Rev 2014

Example Lille Inhouse protocol Markers of CAA? Look at intracranial vessels If no feasable CTA Repeat DSA Domingues R. Neurol Clin 2015

Woman, 59 y Hypertension treated with diuretics (blood pressure @ home: 130/90) 13h15: movements of the right superior lips (seizures?) during 30 min + dysarthria Admission: 14h42, NIHSS 1 (dysarthria) BP: 160/100 Brain imaging: 14h58

TAKE HOME MESSAGE Forget Primary Ask the radiologist Is there an underlying vascular lesion? Is there a cerebral venous thrombosis? «What is the cause» will inform management & prognosis Risk of recurrent ICH? The cause will have impact on your management FORGET PRIMARY

INTRACEREBRAL HAEMORRHAGE: WHAT IS THE CAUSE? Prof. Charlotte Cordonnier Department of neurology & stroke centre Lille University Hospital France charlotte.cordonnier@univ-lille2.fr